logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Acute Myelogenous Leukemia 1st Edition Farhad Ravandi Francis Giles Auth

  • SKU: BELL-4395972
Acute Myelogenous Leukemia 1st Edition Farhad Ravandi Francis Giles Auth
$ 31.00 $ 45.00 (-31%)

4.8

94 reviews

Acute Myelogenous Leukemia 1st Edition Farhad Ravandi Francis Giles Auth instant download after payment.

Publisher: Humana Press
File Extension: PDF
File size: 43.16 MB
Pages: 426
Author: Farhad Ravandi, Francis Giles (auth.), Judith E. Karp MD (eds.)
ISBN: 9781588296214, 9781597453226, 1588296210, 1597453226
Language: English
Year: 2007
Edition: 1

Product desciption

Acute Myelogenous Leukemia 1st Edition Farhad Ravandi Francis Giles Auth by Farhad Ravandi, Francis Giles (auth.), Judith E. Karp Md (eds.) 9781588296214, 9781597453226, 1588296210, 1597453226 instant download after payment.

Acute Myelogenous Leukemia is a timely compilation of new concepts in the molecular pathogenesis and molecular therapy of acute myelogenous leukemia (AML). The focus is on selected critical molecular determinants of AML pathogenesis and pathophysiology and the exploitation of these factors by diverse therapeutic agents and modalities. Bringing together new concepts and findings in the basic and clinical science of AML, the book emphasizes the molecular basis for new therapies that stand to have the greatest potential impact on the clinical face of these diseases. The text provides insights into selected novel strategies currently and prospectively being developed, including interruption of specific signal transduction pathways, modulation of gene expression, attempts to reinstate differentiation, and immunomodulation. There is an emphasis throughout on the bidirectional flow of knowledge between the clinical and laboratory arenas, and both basic and clinical scientists will benefit from this translational text.

Related Products